MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Kythera Biopharmaceuticals Company Profile (NASDAQ:KYTH)

Consensus Ratings for Kythera Biopharmaceuticals (NASDAQ:KYTH) (?)
Ratings Breakdown: 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $62.00 (17.31% downside)

Analysts' Ratings History for Kythera Biopharmaceuticals (NASDAQ:KYTH)
Show:
DateFirmActionRatingPrice TargetActions
6/29/2015Leerink SwannDowngradeOutperform -> Market Perform$61.00 -> $75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2015GuggenheimInitiated CoverageBuy$64.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/10/2015Bank of AmericaInitiated CoverageBuy$66.00 -> $47.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/12/2015Leerink SwannBoost Price TargetOutperform$50.00 -> $61.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/11/2014FBR & Co.Lower Price TargetOutperform$62.00 -> $59.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 2/13/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by the American Association of Individual Investors As Featured by Seeking Alpha